CPHI India & PMEC India 2026 to Connect India’s Pharmaceutical Value Chain Across Ingredients, Manufacturing and Technology

New Delhi, October XX, 2026: CPHI India and PMEC India 2026, organised by Informa Markets in India, will bring together stakeholders from across the pharmaceutical value chain from November 23–26, 2026, across two specialised venues in Delhi-NCR. CPHI India will take place from November 23–25 at IICC, Yashobhoomi, Dwarka, while PMEC India will run from November 24–26 at IEML, Greater Noida. The expanded format is designed to connect the pharmaceutical ingredients, contract manufacturing, machinery and technology sectors, facilitating business engagement, knowledge exchange and industry partnerships.

The 2026 edition is expected to feature 2,000+ exhibitors, welcome 50,000+ pharmaceutical professionals and visitors, and attract participation from 120+ countries. CPHI India will focus on active pharmaceutical ingredients (APIs), finished dosage, excipients, natural extracts, fine chemicals, intermediates and contract development and manufacturing organisations (CDMOs). PMEC India will showcase pharmaceutical machinery, equipment, packaging, laboratory and analytical systems, cleanroom technology and related manufacturing solutions.

The two events will offer complementary platforms for manufacturers, suppliers, research and development professionals, procurement teams and technology providers to assess solutions, explore sourcing opportunities and build partnerships across domestic and international markets. The Connections Programme will offer eligible buyers curated, pre-arranged meetings with exhibitors, while the Startup Market package will enable eligible businesses to showcase their solutions and connect with potential customers and partners.

A Connected Experience Across Two Specialised Venues

With CPHI India and PMEC India taking place at separate venues for the first time, the visitor experience has been designed to facilitate access to both exhibitions. A single visitor badge will provide entry to both events, while complimentary shuttle services will connect IICC, Yashobhoomi, Dwarka, and IEML, Greater Noida. The arrangement will allow visitors to explore pharmaceutical ingredients, contract manufacturing, production machinery and related technologies through one integrated visit.

India’s Pharmaceutical Industry: Scale, Exports and Manufacturing Priorities

India's pharmaceutical industry recorded an annual turnover of ₹4.72 lakh crore in FY2024–25 and ranks third globally by production volume. The sector comprises more than 3,000 companies and 10,500 manufacturing units, supported by a broad ecosystem spanning APIs, formulations, contract manufacturing, research, packaging and pharmaceutical production technologies.

Pharmaceutical exports reached approximately USD 30.5 billion in FY2024–25, registering year-on-year growth of 9.4%, with shipments reaching 191 countries. Around half of these exports were directed to highly regulated markets, including the United States and Europe. India's domestic pharmaceutical market, estimated at around USD 60 billion, is projected to reach approximately USD 130 billion by 2030.

As the industry responds to evolving global requirements, investments in manufacturing efficiency, advanced formulations, API capabilities, automation, packaging, laboratory systems and quality assurance will remain important to strengthening competitiveness and meeting international standards.

Against this backdrop, CPHI India and PMEC India will provide a platform for industry stakeholders to assess emerging technologies, exchange insights on manufacturing priorities and identify business opportunities across the pharmaceutical value chain.

Conference, Leadership and Industry Engagement

The events will address key industry themes spanning market trends, regulation, pharmaceutical manufacturing, outsourcing, emerging technologies, supply chains, sustainability and biopharma, including cell and gene therapies.

Pharma Connect, a two-day conference scheduled for November 23–24, 2026, will feature industry leaders including Dr. Declan Byrne of the European Directorate for the Quality of Medicines & HealthCare (EDQM), Devender Kumar Singh of Pfizer Inc., and Vaibhavi Shah and Dr. Ankur Shah of Invengene. Sessions will explore India's ambition to strengthen its position in API manufacturing, the growth of the CDMO sector, and developments in cell and gene therapy.

CPHI India will also host the India Pharma Awards 2026, the Pharma Leadership Exchange and Women in Pharma. PMEC India will feature a CXO Roundtable and a Regulators Panel Discussion. Together, these initiatives will support knowledge exchange, industry dialogue and connections between business leaders, manufacturers, suppliers and technology providers.

Key exhibitors at CPHI India include IMCD India Pvt Ltd (Signet), Dr. Reddy’s Laboratories Ltd, Akums Drugs and Pharmaceuticals Ltd, Morepen Laboratories Limited and Hetero Labs Limited, among others. Leading exhibitors at PMEC India include Fette Compacting Machinery India Private Limited, ACG Pam Pharma Technologies Pvt. Ltd., Parle Global Technologies Pvt. Ltd., IMA-PG India Pvt. Ltd. and Ace Technologies & Packaging Systems Pvt. Ltd.

The events have also garnered considerable support from association partners including OPPI, IPEC India, BDMAI, GPMA and KDPMA, representing stakeholders across the pharmaceutical value chain.

Industry Perspective

“India’s pharmaceutical industry is strengthening its manufacturing capabilities and global competitiveness. Government data shows that the pharmaceutical drugs PLI scheme generated approximately 1.15 lakh jobs by March 2026, reflecting the sector’s manufacturing potential. With investment in APIs, formulations, automation and quality systems becoming increasingly important, CPHI India and PMEC India 2026 will connect manufacturers, ingredient suppliers, CDMOs and technology providers through specialised platforms and targeted business interactions.

This year, the dual-venue expanded structure of the expos is designed to further help industry stakeholders explore partnerships, identify solutions and pursue new business opportunities across the pharmaceutical value chain in a focused manner.””

Mr. Yogesh Mudras | Managing Director, Informa Markets in India

Event Details

Visitor access: A single visitor badge provides access to both events. Complimentary shuttle services will connect the two venues.

Register to visit: [INSERT REGISTRATION LINK]

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days a year. For more information, please visit www.informamarkets.com

About Informa Markets and our business in India

Informa Markets is owned by Informa PLC, a leading B2B information services group and the largest B2B Events organizer in the world. Informa Markets in India (formerly UBM India) is India’s leading exhibition organizer, dedicated to help specialist markets and customer communities, domestically and around the world to trade, innovate and grow through exhibitions, digital content & services, and conferences & seminars. Every year, we host over 25 large-scale exhibitions, and 40 conferences, along with industry awards and training across the country: thereby enabling trade across multiple industry verticals. In India, Informa Markets has offices in Mumbai and New Delhi.

For any media queries, please contact:

Roshni Mitra Roshni.mitra@informa.com

Milhi Lallwani mili.lalwani@informa.com